| Tara B Lanier, CRNA | |
|
8212 Summa Ave, Baton Rouge, LA 70809-3421 | |
| (225) 769-4403 | |
| (225) 769-3842 |
| Full Name | Tara B Lanier |
|---|---|
| Gender | Female |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 29 Years |
| Location | 8212 Summa Ave, Baton Rouge, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437280112 | NPI | - | NPPES |
| 1686158 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 046409 01677 (Louisiana) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Youngs Professional Services Llc | 2163524992 | 239 |
News Archive
Premier Patient Health Care and Encompass Home Health & Hospice are pleased to announce a new partnership that actively manages the quality and cost of care for patients across multiple settings, in order to meet quality benchmarks and improve patient outcomes.
Thousands of infants each year have exposure to opioids before they are born. Over half of these infants are born with withdrawal symptoms severe enough to require opioid replacement treatment in the nursery. Such treatment is associated with long hospital stays which interferes with maternal/infant bonding. Now, a team of researchers at Thomas Jefferson University has tested a semi-synthetic opioid they say has the potential to improve the treatment of these newborns, which could save hundreds of millions in healthcare costs annually if future tests continue to show benefit.
Keryx Biopharmaceuticals, Inc. today announced that two posters on KRX-0401 were presented at the 102nd annual meeting of the American Association for Cancer Research currently ongoing at the Orange County Convention Center in Orlando, Florida. Perifosine, the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase pathway, is currently in Phase 3 clinical trials for refractory advanced colorectal cancer and multiple myeloma.
Sleep is a crucial part of human health. Piling up a chronic sleep debt by consistently sleeping less than is needed for a fully rested feeling causes a number of illnesses, including heart disease, cancer and autoimmune conditions.
› Verified 6 days ago
| Entity Name | Anesthesiology Group Associates Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255399598 PECOS PAC ID: 0042110298 Enrollment ID: O20040113000117 |
News Archive
Premier Patient Health Care and Encompass Home Health & Hospice are pleased to announce a new partnership that actively manages the quality and cost of care for patients across multiple settings, in order to meet quality benchmarks and improve patient outcomes.
Thousands of infants each year have exposure to opioids before they are born. Over half of these infants are born with withdrawal symptoms severe enough to require opioid replacement treatment in the nursery. Such treatment is associated with long hospital stays which interferes with maternal/infant bonding. Now, a team of researchers at Thomas Jefferson University has tested a semi-synthetic opioid they say has the potential to improve the treatment of these newborns, which could save hundreds of millions in healthcare costs annually if future tests continue to show benefit.
Keryx Biopharmaceuticals, Inc. today announced that two posters on KRX-0401 were presented at the 102nd annual meeting of the American Association for Cancer Research currently ongoing at the Orange County Convention Center in Orlando, Florida. Perifosine, the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase pathway, is currently in Phase 3 clinical trials for refractory advanced colorectal cancer and multiple myeloma.
Sleep is a crucial part of human health. Piling up a chronic sleep debt by consistently sleeping less than is needed for a fully rested feeling causes a number of illnesses, including heart disease, cancer and autoimmune conditions.
› Verified 6 days ago
| Entity Name | Youngs Professional Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1922178599 PECOS PAC ID: 2163524992 Enrollment ID: O20070226000608 |
News Archive
Premier Patient Health Care and Encompass Home Health & Hospice are pleased to announce a new partnership that actively manages the quality and cost of care for patients across multiple settings, in order to meet quality benchmarks and improve patient outcomes.
Thousands of infants each year have exposure to opioids before they are born. Over half of these infants are born with withdrawal symptoms severe enough to require opioid replacement treatment in the nursery. Such treatment is associated with long hospital stays which interferes with maternal/infant bonding. Now, a team of researchers at Thomas Jefferson University has tested a semi-synthetic opioid they say has the potential to improve the treatment of these newborns, which could save hundreds of millions in healthcare costs annually if future tests continue to show benefit.
Keryx Biopharmaceuticals, Inc. today announced that two posters on KRX-0401 were presented at the 102nd annual meeting of the American Association for Cancer Research currently ongoing at the Orange County Convention Center in Orlando, Florida. Perifosine, the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase pathway, is currently in Phase 3 clinical trials for refractory advanced colorectal cancer and multiple myeloma.
Sleep is a crucial part of human health. Piling up a chronic sleep debt by consistently sleeping less than is needed for a fully rested feeling causes a number of illnesses, including heart disease, cancer and autoimmune conditions.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Tara B Lanier, CRNA 7777 Hennessy Blvd, Ste 301, Baton Rouge, LA 70808-0319 Ph: (225) 769-4403 | Tara B Lanier, CRNA 8212 Summa Ave, Baton Rouge, LA 70809-3421 Ph: (225) 769-4403 |
News Archive
Premier Patient Health Care and Encompass Home Health & Hospice are pleased to announce a new partnership that actively manages the quality and cost of care for patients across multiple settings, in order to meet quality benchmarks and improve patient outcomes.
Thousands of infants each year have exposure to opioids before they are born. Over half of these infants are born with withdrawal symptoms severe enough to require opioid replacement treatment in the nursery. Such treatment is associated with long hospital stays which interferes with maternal/infant bonding. Now, a team of researchers at Thomas Jefferson University has tested a semi-synthetic opioid they say has the potential to improve the treatment of these newborns, which could save hundreds of millions in healthcare costs annually if future tests continue to show benefit.
Keryx Biopharmaceuticals, Inc. today announced that two posters on KRX-0401 were presented at the 102nd annual meeting of the American Association for Cancer Research currently ongoing at the Orange County Convention Center in Orlando, Florida. Perifosine, the Company's novel, potentially first-in-class, oral anti-cancer agent that inhibits Akt activation in the phosphoinositide 3-kinase pathway, is currently in Phase 3 clinical trials for refractory advanced colorectal cancer and multiple myeloma.
Sleep is a crucial part of human health. Piling up a chronic sleep debt by consistently sleeping less than is needed for a fully rested feeling causes a number of illnesses, including heart disease, cancer and autoimmune conditions.
› Verified 6 days ago
Toni Tolar, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 8325 Kelwood Ave, Baton Rouge, LA 70806 Phone: 225-929-7600 Fax: 225-930-7524 | |
Holli B Cordell, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 7145 Perkins Road, Baton Rouge, LA 70808 Phone: 225-769-4403 Fax: 225-769-4403 | |
Amy Johnson, C.R.N.A. Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 7777 Hennessy Blvd, Suite 301, Baton Rouge, LA 70808 Phone: 225-214-6438 | |
Mrs. Courtney Day Passman, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 7145 Perkins Road, Baton Rouge, LA 70808 Phone: 225-765-3111 Fax: 225-765-3114 | |
Denise N Baumgartner, CRNA Nurse Anesthetist - CR Medicare: Not Enrolled in Medicare Practice Location: 8212 Summa Ave, Baton Rouge, LA 70809 Phone: 225-769-4403 Fax: 225-769-3842 | |
Kaley Mcclure, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 5000 Hennessy Blvd, Baton Rouge, LA 70808 Phone: 225-765-8541 | |
Alton J Ardoin, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 7855 Howell Blvd, Baton Rouge, LA 70807 Phone: 225-358-4900 |